Literature DB >> 28341600

Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.

Annadurai Anandhan1, Maria S Jacome2, Shulei Lei3, Pablo Hernandez-Franco1, Aglaia Pappa4, Mihalis I Panayiotidis5, Robert Powers6, Rodrigo Franco7.   

Abstract

The loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the accumulation of protein inclusions (Lewy bodies) are the pathological hallmarks of Parkinson's disease (PD). PD is triggered by genetic alterations, environmental/occupational exposures and aging. However, the exact molecular mechanisms linking these PD risk factors to neuronal dysfunction are still unclear. Alterations in redox homeostasis and bioenergetics (energy failure) are thought to be central components of neurodegeneration that contribute to the impairment of important homeostatic processes in dopaminergic cells such as protein quality control mechanisms, neurotransmitter release/metabolism, axonal transport of vesicles and cell survival. Importantly, both bioenergetics and redox homeostasis are coupled to neuro-glial central carbon metabolism. We and others have recently established a link between the alterations in central carbon metabolism induced by PD risk factors, redox homeostasis and bioenergetics and their contribution to the survival/death of dopaminergic cells. In this review, we focus on the link between metabolic dysfunction, energy failure and redox imbalance in PD, making an emphasis in the contribution of central carbon (glucose) metabolism. The evidence summarized here strongly supports the consideration of PD as a disorder of cell metabolism.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioenergetics; Glucose; Glycolysis; Mitochondria; Neurodegeneration; Oxidative stress; TCA cycle

Mesh:

Substances:

Year:  2017        PMID: 28341600      PMCID: PMC5555796          DOI: 10.1016/j.brainresbull.2017.03.009

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  353 in total

1.  High frequency of mitochondrial complex I mutations in Parkinson's disease and aging.

Authors:  Rafal Smigrodzki; Janice Parks; W Davis Parker
Journal:  Neurobiol Aging       Date:  2004 Nov-Dec       Impact factor: 4.673

2.  Energy status, ubiquitin proteasomal function, and oxidative stress during chronic and acute complex I inhibition with rotenone in mesencephalic cultures.

Authors:  Gail D Zeevalk; Laura P Bernard
Journal:  Antioxid Redox Signal       Date:  2005 May-Jun       Impact factor: 8.401

3.  The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited.

Authors:  K Nakamura; V P Bindokas; J D Marks; D A Wright; D M Frim; R J Miller; U J Kang
Journal:  Mol Pharmacol       Date:  2000-08       Impact factor: 4.436

4.  Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex.

Authors:  Kyung-Ae Ji; Mi Young Eu; Seung-Hee Kang; Byoung Joo Gwag; Ilo Jou; Eun-Hye Joe
Journal:  Glia       Date:  2008-08-01       Impact factor: 7.452

Review 5.  Proteins in microglial activation--inputs and outputs by subsets.

Authors:  Uwe-Karsten Hanisch
Journal:  Curr Protein Pept Sci       Date:  2013-02       Impact factor: 3.272

6.  Increased brain uptake and oxidation of acetate in heavy drinkers.

Authors:  Lihong Jiang; Barbara Irene Gulanski; Henk M De Feyter; Stuart A Weinzimer; Brian Pittman; Elizabeth Guidone; Julia Koretski; Susan Harman; Ismene L Petrakis; John H Krystal; Graeme F Mason
Journal:  J Clin Invest       Date:  2013-03-08       Impact factor: 14.808

7.  Role of glutamate in neuron-glia metabolic coupling.

Authors:  Pierre J Magistretti
Journal:  Am J Clin Nutr       Date:  2009-07-01       Impact factor: 7.045

8.  Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine.

Authors:  Y Glinka; K F Tipton; M B Youdim
Journal:  Eur J Pharmacol       Date:  1998-06-12       Impact factor: 4.432

9.  PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.

Authors:  Péter Bai; Carles Cantó; Hugues Oudart; Attila Brunyánszki; Yana Cen; Charles Thomas; Hiroyasu Yamamoto; Aline Huber; Borbála Kiss; Riekelt H Houtkooper; Kristina Schoonjans; Valérie Schreiber; Anthony A Sauve; Josiane Menissier-de Murcia; Johan Auwerx
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

10.  DJ-1 links muscle ROS production with metabolic reprogramming and systemic energy homeostasis in mice.

Authors:  Sally Yu Shi; Shun-Yan Lu; Tharini Sivasubramaniyam; Xavier S Revelo; Erica P Cai; Cynthia T Luk; Stephanie A Schroer; Prital Patel; Raymond H Kim; Eric Bombardier; Joe Quadrilatero; A Russell Tupling; Tak W Mak; Daniel A Winer; Minna Woo
Journal:  Nat Commun       Date:  2015-06-16       Impact factor: 14.919

View more
  38 in total

1.  Metabolomics Analyses from Tissues in Parkinson's Disease.

Authors:  Fatema Bhinderwala; Shulei Lei; Jade Woods; Jordan Rose; Darrell D Marshall; Eli Riekeberg; Aline De Lima Leite; Martha Morton; Eric D Dodds; Rodrigo Franco; Robert Powers
Journal:  Methods Mol Biol       Date:  2019

Review 2.  Role of the chanzyme TRPM7 in the nervous system in health and disease.

Authors:  Nashat Abumaria; Wei Li; Andrew N Clarkson
Journal:  Cell Mol Life Sci       Date:  2019-05-09       Impact factor: 9.261

3.  Early Sociability and Social Memory Impairment in the A53T Mouse Model of Parkinson's Disease Are Ameliorated by Chemogenetic Modulation of Orexin Neuron Activity.

Authors:  Milos Stanojlovic; Jean Pierre Pallais Yllescas; Aarthi Vijayakumar; Catherine Kotz
Journal:  Mol Neurobiol       Date:  2019-06-27       Impact factor: 5.590

4.  Paraquat Exposure Increases Oxidative Stress Within the Dorsal Striatum of Male Mice With a Genetic Deficiency in One-carbon Metabolism.

Authors:  Nafisa M Jadavji; Lauren K Murray; Joshua T Emmerson; Chris A Rudyk; Shawn Hayley; Patrice D Smith
Journal:  Toxicol Sci       Date:  2019-05-01       Impact factor: 4.849

5.  Clustering of Alzheimer's and Parkinson's disease based on genetic burden of shared molecular mechanisms.

Authors:  Mohammad Asif Emon; Ashley Heinson; Ping Wu; Daniel Domingo-Fernández; Meemansa Sood; Henri Vrooman; Jean-Christophe Corvol; Phil Scordis; Martin Hofmann-Apitius; Holger Fröhlich
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

6.  Perillyl Alcohol Mitigates Behavioural Changes and Limits Cell Death and Mitochondrial Changes in Unilateral 6-OHDA Lesion Model of Parkinson's Disease Through Alleviation of Oxidative Stress.

Authors:  Ehraz Anis; Mohd Faraz Zafeer; Fakiha Firdaus; Shireen Naaz Islam; Azka Anees Khan; M Mobarak Hossain
Journal:  Neurotox Res       Date:  2020-05-11       Impact factor: 3.911

7.  Evaluation of the Mitochondria-Related Redox and Bioenergetics Effects of Gastrodin in SH-SY5Y Cells Exposed to Hydrogen Peroxide.

Authors:  Marcos Roberto de Oliveira; Flávia Bittencourt Brasil; Cristina Ribas Fürstenau
Journal:  J Mol Neurosci       Date:  2018-01-12       Impact factor: 3.444

8.  LIN28A loss of function is associated with Parkinson's disease pathogenesis.

Authors:  Mi-Yoon Chang; Boram Oh; Jang-Eun Choi; Yanuar Alan Sulistio; Hye-Ji Woo; Ayoung Jo; Jinil Kim; Eun-Hee Kim; Seung Won Kim; Jungwook Hwang; Jungyun Park; Jae-Jin Song; Oh-Chan Kwon; Hyongbum Henry Kim; Young-Hoon Kim; Joo Yeon Ko; Jun Young Heo; Min Joung Lee; Moses Lee; Murim Choi; Sun Ju Chung; Hyun-Seob Lee; Sang-Hun Lee
Journal:  EMBO J       Date:  2019-11-21       Impact factor: 11.598

9.  Complex epigenetic patterns in cerebellum generated after developmental exposure to trichloroethylene and/or high fat diet in autoimmune-prone mice.

Authors:  Sarah J Blossom; Stepan B Melnyk; Frank A Simmen
Journal:  Environ Sci Process Impacts       Date:  2020-01-02       Impact factor: 4.238

10.  Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease.

Authors:  Milos Stanojlovic; Jean Pierre Pallais; Michael K Lee; Catherine M Kotz
Journal:  Mol Brain       Date:  2019-10-30       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.